Amplia CEO and Managing Director, Dr John Lambert, will be presenting at the Proactive Lifesciences Webinar at 12 noon AEST on Tuesday 28 September 2021.
If you’re interested to learn more about the results from our successful Phase 1 clinical trial, and plans for our Phase 2 clinical trial of AMP945 in first line pancreatic cancer patients, we invite you to register your attendance.
Click here to register: https://bit.ly/Proactive_Webinar_Registration
